文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

学术医疗系统中COVID-19结局的种族/民族差异相关特征

Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.
PubMed 文献 · JAMA Netw Open · 2020-10-01
一句话结论在校正年龄、性别、社会经济状况和合并症评分后,黑人患者因COVID-19住院的几率高于白人患者(OR 1.72),但ICU入住和死亡率无显著种族差异。

这项回顾性队列研究纳入了密歇根大学2020年3月10日至4月22日接受COVID-19检测或治疗的5698例患者,并随机选取7168例未检测者作为对照,随访至2020年7月28日。在1139例确诊患者中,校正年龄、性别、社会经济状况和合并症评分后,黑人患者住院几率高于白人患者(OR 1.72,95%CI 1.15-2.58)。此外,老年、男性、肥胖、居住在高人口密度地区、既存2型糖尿病和肾病与住院风险升高相关。风险因素与COVID-19结局的关联因种族而异,但ICU入住和死亡率无显著种族差异。

要点

  • 在总体人群中,既存2型糖尿病(OR 1.82,95%CI 1.25-2.64)和肾病(OR 2.87,95%CI 1.87-4.42)与住院风险升高相关。

适用人群与场景

  • 2020年3月10日至4月22日在密歇根大学接受COVID-19检测或治疗的患者(5698例),以及随机选取的未检测个体(7168例)作为对照;随访至2020年7月28日。
  • 纳入分析的因素包括种族/民族、年龄、吸烟、饮酒、合并症、BMI和居住地社会经济特征;未提及具体的排除标准。

诊断标准与关键阈值

  • COVID-19检测阳性定义为院内PCR、商业抗体检测、密歇根州卫生与公众服务部部署的鼻咽/口咽PCR或外部实验室逆转录PCR检测结果阳性。
  • 合并症根据ICD-9和ICD-10编码定义,并汇总为合并症评分。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入5698例接受COVID-19检测的患者(平均年龄47.4岁,男性38.0%,平均BMI 30.0)和7168例未检测对照(平均年龄43.1岁,男性45.4%,平均BMI 28.5)。
  • 在1139例确诊COVID-19的患者中,492例(43.2%)为白人,442例(38.8%)为黑人;523例(45.9%)住院,283例(24.7%)入住ICU,88例(7.7%)死亡。

证据类型、等级与局限

  • 证据类型为回顾性队列研究;原文未给出证据等级或推荐强度。
  • 原文未述局限性。

对床旁实践的改变

  • 对于COVID-19患者,尤其是黑人患者,应关注既存2型糖尿病和肾病,这些因素与住院风险升高相关;同时需考虑居住在高人口密度地区的影响。
  • 风险因素与COVID-19结局的关联因种族而异:肥胖和癌症与黑人患者检测阳性的关联更强,而总体合并症负担和2型糖尿病与白人患者住院的关联更强。
  • 校正分析未显示ICU入住和死亡率存在显著种族差异,提示住院风险差异可能更多由合并症和社会经济因素解释。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: Black patients are overrepresented in the number of COVID-19 infections, hospitalizations, and deaths in the US. Reasons for this disparity may be due to underlying comorbidities or sociodemographic factors that require further exploration.

OBJECTIVE: To systematically determine patient characteristics associated with racial/ethnic disparities in COVID-19 outcomes.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used comparative groups of patients tested or treated for COVID-19 at the University of Michigan from March 10, 2020, to April 22, 2020, with an outcome update through July 28, 2020. A group of randomly selected untested individuals were included for comparison. Examined factors included race/ethnicity, age, smoking, alcohol consumption, comorbidities, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared), and residential-level socioeconomic characteristics.

EXPOSURE: In-house polymerase chain reaction (PCR) tests, commercial antibody tests, nasopharynx or oropharynx PCR deployed by the Michigan Department of Health and Human Services and reverse transcription-PCR tests performed in external labs.

MAIN OUTCOMES AND MEASURES: The main outcomes were being tested for COVID-19, having test results positive for COVID-19 or being diagnosed with COVID-19, being hospitalized for COVID-19, requiring intensive care unit (ICU) admission for COVID-19, and COVID-19-related mortality (including inpatient and outpatient). Medical comorbidities were defined from the International Classification of Diseases, Ninth Revision, and International Classification of Diseases, Tenth Revision, codes and were aggregated into a comorbidity score. Associations with COVID-19 outcomes were examined using odds ratios (ORs).

RESULTS: Of 5698 patients tested for COVID-19 (mean [SD] age, 47.4 [20.9] years; 2167 [38.0%] men; mean [SD] BMI, 30.0 [8.0]), most were non-Hispanic White (3740 patients [65.6%]) or non-Hispanic Black (1058 patients [18.6%]). The comparison group included 7168 individuals who were not tested (mean [SD] age, 43.1 [24.1] years; 3257 [45.4%] men; mean [SD] BMI, 28.5 [7.1]). Among 1139 patients diagnosed with COVID-19, 492 (43.2%) were White and 442 (38.8%) were Black; 523 (45.9%) were hospitalized, 283 (24.7%) were admitted to the ICU, and 88 (7.7%) died. Adjusting for age, sex, socioeconomic status, and comorbidity score, Black patients were more likely to be hospitalized compared with White patients (OR, 1.72 [95% CI, 1.15-2.58]; P = .009). In addition to older age, male sex, and obesity, living in densely populated areas was associated with increased risk of hospitalization (OR, 1.10 [95% CI, 1.01-1.19]; P = .02). In the overall population, higher risk of hospitalization was also observed in patients with preexisting type 2 diabetes (OR, 1.82 [95% CI, 1.25-2.64]; P = .02) and kidney disease (OR, 2.87 [95% CI, 1.87-4.42]; P < .001). Compared with White patients, obesity was associated with higher risk of having test results positive for COVID-19 among Black patients (White: OR, 1.37 [95% CI, 1.01-1.84]; P = .04. Black: OR, 3.11 [95% CI, 1.64-5.90]; P < .001; P for interaction = .02). Having any cancer was associated with higher risk of positive COVID-19 test results for Black patients (OR, 1.82 [95% CI, 1.19-2.78]; P = .005) but not White patients (OR, 1.08 [95% CI, 0.84-1.40]; P = .53; P for interaction = .04). Overall comorbidity burden was associated with higher risk of hospitalization in White patients (OR, 1.30 [95% CI, 1.11-1.53]; P = .001) but not in Black patients (OR, 0.99 [95% CI, 0.83-1.17]; P = .88; P for interaction = .02), as was type 2 diabetes (White: OR, 2.59 [95% CI, 1.49-4.48]; P < .001; Black: OR, 1.17 [95% CI, 0.66-2.06]; P = .59; P for interaction = .046). No statistically significant racial differences were found in ICU admission and mortality based on adjusted analysis.

CONCLUSIONS AND RELEVANCE: These findings suggest that preexisting type 2 diabetes or kidney diseases and living in high-population density areas were associated with higher risk for COVID-19 hospitalization. Associations of risk factors with COVID-19 outcomes differed by race.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Gu T, Mack JA, Salvatore M, et al. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System. JAMA Netw Open. 2020. PMID: 33084902. doi:10.1001/jamanetworkopen.2020.25197

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。